However, the impaired β cell function observed with T1D serum treatment of human islets was significantly improved in the presence of OPG and DMB, but not with vehicle or IgG treatment (Fig. 9E). This evidence concerns the gene TNFRSF11B and type 1 diabetes mellitus.